Literature DB >> 26093170

Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory.

Michael D Ballinger1, Atsushi Saito1, Bagrat Abazyan1, Yu Taniguchi1, Ching-Hsun Huang1, Koki Ito1, Xiaolei Zhu1, Hadar Segal1, Hanna Jaaro-Peled1, Akira Sawa2, Ken Mackie3, Mikhail V Pletnikov2, Atsushi Kamiya4.   

Abstract

Cannabis is an increasingly popular and controversial drug used worldwide. Cannabis use often begins during adolescence, a highly susceptible period for environmental stimuli to alter functional and structural organization of the developing brain. Given that adolescence is a critical time for the emergence of mental illnesses before full-onset in early adulthood, it is particularly important to investigate how genetic insults and adolescent cannabis exposure interact to affect brain development and function. Here we show for the first time that a perturbation in disrupted in schizophrenia 1 (DISC1) exacerbates the response to adolescent exposure to delta-9-tetrahydrocannabinol (Δ(9)-THC), a major psychoactive ingredient of cannabis, consistent with the concept that gene-environment interaction may contribute to the pathophysiology of psychiatric conditions. We found that chronic adolescent treatment with Δ(9)-THC exacerbates deficits in fear-associated memory in adult mice that express a putative dominant-negative mutant of DISC1 (DN-DISC1). Synaptic expression of cannabinoid receptor 1 (CB1R) is down-regulated in the prefrontal cortex, hippocampus, and amygdala, critical brain regions for fear-associated memory, by either expression of DN-DISC1 or adolescent Δ(9)-THC treatment. Notably, elevation of c-Fos expression evoked by context-dependent fear memory retrieval is impaired in these brain regions in DN-DISC1 mice. We also found a synergistic reduction of c-Fos expression induced by cue-dependent fear memory retrieval in DN-DISC1 with adolescent Δ(9)-THC exposure. These results suggest that alteration of CB1R-mediated signaling in DN-DISC1 mice may underlie susceptibility to detrimental effects of adolescent cannabis exposure on adult behaviors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent development; Chronic cannabis use; DISC1; Fear memory; Gene–environment interaction

Mesh:

Substances:

Year:  2015        PMID: 26093170      PMCID: PMC4640936          DOI: 10.1016/j.nbd.2015.06.006

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  58 in total

1.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

2.  Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.

Authors:  Takatoshi Hikida; Hanna Jaaro-Peled; Saurav Seshadri; Kenichi Oishi; Caroline Hookway; Stephanie Kong; Di Wu; Rong Xue; Manuella Andradé; Stephanie Tankou; Susumu Mori; Michela Gallagher; Koko Ishizuka; Mikhail Pletnikov; Satoshi Kida; Akira Sawa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-03       Impact factor: 11.205

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

4.  Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

Authors:  A W Dunah; D G Standaert
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 5.  Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?

Authors:  André Aleman; René S Kahn
Journal:  Prog Neurobiol       Date:  2005-12-13       Impact factor: 11.685

6.  Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids.

Authors:  Minae Niwa; Hanna Jaaro-Peled; Stephanie Tankou; Saurav Seshadri; Takatoshi Hikida; Yurie Matsumoto; Nicola G Cascella; Shin-ichi Kano; Norio Ozaki; Toshitaka Nabeshima; Akira Sawa
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

7.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Authors:  C C Felder; K E Joyce; E M Briley; J Mansouri; K Mackie; O Blond; Y Lai; A L Ma; R L Mitchell
Journal:  Mol Pharmacol       Date:  1995-09       Impact factor: 4.436

8.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

9.  DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders.

Authors:  Atsushi Kamiya; Thomas W Sedlak; Mikhail V Pletnikov
Journal:  Front Psychiatry       Date:  2012-03-22       Impact factor: 4.157

10.  Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.

Authors:  Roopali Yadav; Brandon G Hillman; Subhash C Gupta; Pratyush Suryavanshi; Jay M Bhatt; Ratnamala Pavuluri; Dustin J Stairs; Shashank M Dravid
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  14 in total

Review 1.  Neural substrates underlying the negative impact of cannabinoid exposure during adolescence.

Authors:  Hanna M Molla; Kuei Y Tseng
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

2.  BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.

Authors:  Hadar Segal-Gavish; Neta Gazit; Yael Barhum; Tali Ben-Zur; Michal Taler; Shay Henry Hornfeld; Irit Gil-Ad; Abraham Weizman; Inna Slutsky; Minae Niwa; Atsushi Kamiya; Akira Sawa; Daniel Offen; Ran Barzilay
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

Review 3.  Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects.

Authors:  Yasmin L Hurd; Olivier J Manzoni; Mikhail V Pletnikov; Francis S Lee; Sagnik Bhattacharyya; Miriam Melis
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

4.  Adolescent Δ9-Tetrahydrocannabinol Exposure and Astrocyte-Specific Genetic Vulnerability Converge on Nuclear Factor-κB-Cyclooxygenase-2 Signaling to Impair Memory in Adulthood.

Authors:  Yan Jouroukhin; Xiaolei Zhu; Alexey V Shevelkin; Yuto Hasegawa; Bagrat Abazyan; Atsushi Saito; Jonathan Pevsner; Atsushi Kamiya; Mikhail V Pletnikov
Journal:  Biol Psychiatry       Date:  2018-08-16       Impact factor: 13.382

Review 5.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

6.  THC exposure during adolescence does not modify nicotine reinforcing effects and relapse in adult male mice.

Authors:  África Flores; Rafael Maldonado; Fernando Berrendero
Journal:  Psychopharmacology (Berl)       Date:  2019-12-19       Impact factor: 4.530

Review 7.  Astrocyte Bioenergetics and Major Psychiatric Disorders.

Authors:  Ivan V Maly; Michael J Morales; Mikhail V Pletnikov
Journal:  Adv Neurobiol       Date:  2021

Review 8.  Utility and validity of DISC1 mouse models in biological psychiatry.

Authors:  T Tomoda; A Sumitomo; H Jaaro-Peled; A Sawa
Journal:  Neuroscience       Date:  2016-01-06       Impact factor: 3.590

Review 9.  Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models.

Authors:  Paula Moran; Jennifer Stokes; Julia Marr; Gavin Bock; Lieve Desbonnet; John Waddington; Colm O'Tuathaigh
Journal:  Neural Plast       Date:  2016-09-20       Impact factor: 3.599

10.  Effects of DISC1 Polymorphisms on Resting-State Spontaneous Neuronal Activity in the Early-Stage of Schizophrenia.

Authors:  Ningzhi Gou; Zhening Liu; Lena Palaniyappan; Mingding Li; Yunzhi Pan; Xudong Chen; Haojuan Tao; Guowei Wu; Xuan Ouyang; Zheng Wang; Taotao Dou; Zhimin Xue; Weidan Pu
Journal:  Front Psychiatry       Date:  2018-05-23       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.